Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.50
Bid: 1,604.00
Ask: 1,604.50
Change: 4.50 (0.28%)
Spread: 0.50 (0.031%)
Open: 1,600.50
High: 1,612.50
Low: 1,591.00
Prev. Close: 1,595.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks mixed after disappointing retail sales data

Fri, 24th May 2024 15:19

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

The FTSE 100 index dipped 0.26%, ending the day at 8,317.59 points, while the FTSE 250 saw a gain of 0.68%, closing at 20,770.93.

In currency markets, sterling was last up 0.34% on the dollar to trade at $1.2742, while it edged up 0.01% against the euro, changing hands at €1.1742.

"Following a disappointing session in Asia and Europe, US stock indices shrug off risk-off sentiment amid this week's 'rates higher for longer' outlook as durable goods orders unexpectedly rise," said IG senior market analyst Axel Rudolph.

"The US two-year yield comes slightly off its Thursday 4.95% high while the 10-year yield stalls at the 4.50% marker with the greenback giving back some of this week's gains."

Rudolph noted that over the course of the week, oil prices dropped more than 3% to a near three-month low amid demand concerns, before managing to heave into the green ahead of next week's online OPEC+ meeting.

"US natural gas prices fall by around 2.5% from their five-month peak while the price of gold remains little changed and that of silver rises by around a percentage point ahead of the weekend.

"Next week the focus will remain on inflation with the Fed's preferred PCE inflation gauge."

Retail sales decline more than expected, but consumer confidence improves

In economic news, retail sales in the UK saw a significant decline in April, according to official data released earlier.

The Office for National Statistics reported that retail sales volumes fell by 2.3% last month, following a revised 0.2% decline in March, previously estimated at 0.0%.

Analysts had anticipated a smaller drop of around 0.5%.

The decline was attributed to poor weather, which kept shoppers at home, leading to decreased sales across most sectors, particularly in clothing, sports equipment, games, toys, and furniture.

Non-food store sales volumes fell by 4.1%.

Despite the monthly drop, sales rose by 0.7% in the three months to April compared to the previous quarter.

However, year-on-year sales were down 2.7%, remaining 3.8% below pre-pandemic levels.

The downturn contrasted with recent positive economic indicators, including improved consumer confidence, inflation returning to 2.3%, and the UK exiting a recession with 0.6% growth.

"There was nothing charming about the rainfall that soaked our high streets in April," said Danni Hewson, head of financial analysis at AJ Bell.

"It didn't help that Easter came early. But even then, March's flatlining sales were revised down.

"Consumers are still looking for ways to keep a tight hold on their stretched finances; if they don't need to spend, they probably won't."

In contrast, UK consumer confidence showed signs of improvement in May.

The GfK consumer confidence index rose two points to -17, driven by increased optimism about the economy and personal finances.

Expectations for the general economic situation over the next year climbed four points to -17, while the forward-looking personal finance situation jumped five points to 7.

However, the major purchase index dipped one point to -26.

"With the latest drop in headline inflation and the prospect of interest rate cuts in due course, the trend is certainly positive after a long period of stasis which has seen the overall index score stuck in the doldrums," said Joe Staton, client strategy director at GfK.

"All-in-all, consumers are clearly sensing that conditions are improving.

"This good result anticipates further growth in confidence in the months to come."

On the continent, Germany's economy grew by 0.2% in the first quarter of 2024, according to the Federal Statistics Office, confirming earlier estimates.

It followed a 0.5% contraction in the fourth quarter of the prior year.

The growth rate for the same period in 2023 was 0.3%.

Across the Atlantic, durable goods orders in the US unexpectedly rose by 0.7% in April to $284.1bn, according to the Department of Commerce.

The increase came despite a sharp downward revision to March's figures, which were adjusted from an initial estimate of 2.6% growth to just 0.8%.

However, US consumer sentiment declined in May, according to the University of Michigan's consumer confidence index.

The index fell from 77.2 in April to 69.1 in May, with subindices tracking views on current economic conditions and future expectations both showing decreases.

Retailers rise despite sales data, National Grid falls further

On London's equity markets, retail stocks were in the green despite the ONS reporting a drop in retail sales for April.

Ocado Group surged by 6.16%, Kingfisher rose by 1.31%, and Marks and Spencer Group climbed 2.26%, as investors seemed unfazed by the disappointing sales data.

Packaging group Mondi saw a 0.89% increase after Citi upgraded the stock to 'buy', citing reversing market headwinds in destocking and lower pricing across Mondi's product segments.

Intertek Group also gained 1.26% after confirming its full-year expectations and reporting a 7% growth in like-for-like revenue, driven by a strong recovery in the consumer products segment.

John Wood Group rallied 4.5% after rejecting a third improved takeover proposal from Dubai-based Sidara.

The oil services company stated that the offer of 220p per share still "significantly undervalued" the group and its prospects.

Sidara has until 5 June to make a firm bid.

On the downside, GSK dipped by 0.2%, reversing earlier gains despite a favourable court ruling in Illinois regarding the first Zantac case to go to trial.

National Grid plummeted by 11.5%, continuing its decline after announcing plans for a £7bn equity raise through a rights issue.

United Utilities Group and Severn Trent were also in the red, falling 1.48% and 2.16% respectively.

AJ Bell dropped 3.77% after founder Andy Bell sold 7.5 million shares in the investment platform at 375p each, raising around £28.1m.

Hargreaves Lansdown fell by 3.14% following confirmation that it had rejected a 985p per share takeover offer from a consortium including CVC, Nordic Capital, and Platinum Ivy, a subsidiary of Abu Dhabi Investment Authority.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 8,317.59 -0.26%

FTSE 250 (MCX) 20,770.93 0.68%

techMARK (TASX) 4,853.89 -0.05%

FTSE 100 - Risers

Ocado Group (OCDO) 373.80p 6.16%

Marks & Spencer Group (MKS) 299.20p 2.26%

Intertek Group (ITRK) 5,025.00p 1.43%

Airtel Africa (AAF) 121.00p 1.42%

Phoenix Group Holdings (PHNX) 503.00p 1.41%

Smurfit Kappa Group (CDI) (SKG) 3,882.00p 1.36%

Kingfisher (KGF) 260.90p 1.31%

Legal & General Group (LGEN) 247.90p 1.10%

Aviva (AV.) 488.10p 1.08%

CRH (CDI) (CRH) 6,406.00p 1.04%

FTSE 100 - Fallers

National Grid (NG.) 889.40p -11.50%

RS Group (RS1) 740.50p -2.57%

Fresnillo (FRES) 596.00p -2.21%

Severn Trent (SVT) 2,449.00p -2.16%

Centrica (CNA) 141.15p -1.91%

Smith (DS) (SMDS) 369.60p -1.81%

Haleon (HLN) 323.00p -1.79%

Sage Group (SGE) 1,059.50p -1.76%

Lloyds Banking Group (LLOY) 54.80p -1.76%

SSE (SSE) 1,740.50p -1.64%

FTSE 250 - Risers

Ferrexpo (FXPO) 47.50p 5.79%

NCC Group (NCC) 145.80p 5.19%

Wood Group (John) (WG.) 188.00p 5.17%

SDCL Energy Efficiency Income Trust (SEIT) 64.90p 5.02%

Direct Line Insurance Group (DLG) 210.40p 4.89%

Ibstock (IBST) 171.60p 3.62%

Paragon Banking Group (PAG) 768.50p 3.50%

Plus500 Ltd (DI) (PLUS) 2,234.00p 3.33%

Watches of Switzerland Group (WOSG) 407.80p 3.18%

Travis Perkins (TPK) 858.00p 3.13%

FTSE 250 - Fallers

Essentra (ESNT) 166.40p -4.91%

AJ Bell (AJB) 384.50p -4.59%

Trustpilot Group (TRST) 221.50p -3.08%

PPHE Hotel Group Ltd (PPH) 1,350.00p -2.88%

Hargreaves Lansdown (HL.) 1,090.00p -2.68%

Kainos Group (KNOS) 1,236.00p -2.56%

QinetiQ Group (QQ.) 413.60p -2.54%

TBC Bank Group (TBCG) 2,660.00p -2.21%

Tritax Eurobox (GBP) (EBOX) 55.80p -1.76%

Drax Group (DRX) 499.20p -1.64%

More News
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.